A logo of Eli Lilly & Co. is seen in a bottle bottle cover in the photo pics at a pharmacy in Princeton, Illinois.
Daniel Acker | Bloomberg | Getty Images
The sale of pharmaceutical giant Pfizer and Merck grew more than 1% in trading premarket on Tuesday after reporting financial results in the first quarter to beat Wall Street's expectations.
However, distributors of the drug giant Eli Lilly dropped by 3.0% after the company reported the first-quarter earnings earned, but the revenue was not recovered. Eli Lilly's main drugs were Trulicity and Alimta failed on Wall Street bets.
Health care is the worst performing sector in the stock market this year on concerns about drug price reform and Medicare for All proposals from Democrats. The Health Care Select Sector SPDR Fund, an ETF that tracks the largest healthcare industry companies, only reached 2.7% on Monday, significantly falling into the broader market index. The Dow Jones Industrial Average is 13% over the same period, and S & P 500 is 17% higher.
For more on investing in health care innovation, click here to join CNBC at our Healthy Returns Summit in New York City on May 21.